Cost-effectiveness of Korea's national cervical cancer screening program

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 7, 2013, Pages 4329-4334

  Cho, Eun ^a   Kang, Moon Hae ^b   Choi, Kui Son ^c   Suh, MiNa ^c   Jun, Jae Kwan ^c   Park, Eun Cheol ^b,d  

^a Sookmyung Women's University   (South Korea)

^b Yonsei University   (South Korea)

^c National Cancer Center   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Cervical cancer; Cost effectiveness; Korea; Mass screening; Pap smear

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; ECONOMICS; FEMALE; FOLLOW UP; HUMAN; MIDDLE AGED; MORTALITY; PROGNOSIS; PUBLIC HEALTH; SOUTH KOREA; SURVIVAL RATE; UTERINE CERVIX TUMOR;

ADULT; AGED; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; NEOPLASM STAGING; PROGNOSIS; REPUBLIC OF KOREA; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 84885464819     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.7.4329     Document Type: Article

References (31)

1. Chen MK, Hung HF, Duffy S, et al (2011). Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination. J Eval Clin Pract, 17, 1050-8.
2. Cho E, Kang MH, Choi KS, et al (2013). Cost-effectiveness Outcomes of the National Gastric Cancer Screening Program in South Korea. Asian Pac J Cancer Prev, 14, 2533-40.
3. Chung HH, Jang MJ, Jung KW, et al (2006). Cervical cancer incidence and survival in Korea: 1993-2002. Int J Gynecol Cancer, 16, 1833-8.
4. Ezat WP, Aljunid S (2010). Cost-effectiveness of HPV vaccination in the prevention of cervical cancer in Malaysia. Asian Pac J Cancer Prev, 11, 79-90.
5. Flores YN, Bishai DM, Lorincz A, et al (2011). HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico. Cancer Causes Control, 22, 261-72.
6. Forouzanfar MH, Foreman KJ, Delossantos AM, et al (2011). Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. The Lancet, 378, 1461-84.
7. Gravitt PE, Paul P, Katki HA, et al (2010). Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India. PLoS One, 5, 13711.
8. Hahm MI, Choi KS, Lee HY, et al (2011). Who participates in the gastric cancer screening and on-time rescreening in the National Cancer Screening Program? A population-based study in Korea. Cancer Sci, 102, 2241-7.
9. Han MA, Jun JK, Choi KS, et al (2012). Satisfaction in the National Cancer Screening Program for breast cancer with and without clinical breast examination. Asian Pac J Cancer Prev, 13, 63-7.
10. Jun JK, Choi KS, Jung KW, et al (2009). Effectiveness of an organized cervical cancer screening program in Korea: results from a cohort study. Int J Cancer, 124, 188-93.
11. Jung KW, Shin HR, Kong HJ, et al (2010). Long-term trends in cancer mortality in Korea (1983-2007): a joinpoint regression analysis. Asian Pac J Cancer Prev, 11, 1451-7.
12. Jung KW, Yim SH, Kong HJ, et al (2007). Cancer survival in Korea 1993-2002: a population-based study. J Korean Med Sci, 22, 5-10.
13. Kim JH, Kim IW, Kim YW, et al (2013). Comparison of single-, double- and triple-combined testing, including Pap test, HPV DNA test and cervicography, as screening methods for the detection of uterine cervical cancer. Oncol Rep, 29, 1645-51.
14. Kim SJ, Namkoong SE, Lee JM, et al (1994). Cervical cancer control in Korea: colposcopy/cervicograph/cytology. Arch AIDS Res, 8, 101-11.
15. Kim Y, Jun JK, Choi KS, et al (2011). Overview of the National Cancer screening programme and the cancer screening status in Korea. Asian Pac J Cancer Prev, 12, 725-30.
16. Konno R, Shin H-R, Kim Y-T, et al (2008). Human Papillomavirus Infection and Cervical Cancer Prevention in Japan and Korea. Vaccine, 26, 30-42.
17. Koong SL, Yen AM, Chen TH (2006). Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan. J Med Screen, 13, 44-7.
18. Korean Statistical Information Service (KOSIS) (2012). http://kosis.kr/index/index.jsp.
19. Lee HY, Lim SM, Han MA, et al (2011). Assessment of participant satisfaction with upper gastrointestinal endoscopy in South Korea. World J Gastroenterol, 17, 4124-9.
20. Levin CE, Sellors J, Shi JF, et al (2010). Cost-effectiveness analysis of cervical cancer prevention based on a rapid human papillomavirus screening test in a high-risk region of China. Int J Cancer, 127, 1404-11.
21. Park MJ, Park EC, Choi KS, et al (2011). Sociodemographic gradients in breast and cervical cancer screening in Korea: the Korean National Cancer Screening Survey (KNCSS) 2005-2009. BMC Cancer, 11, 257.
22. Praditsitthikorn N, Teerawattananon Y, Tantivess S, et al (2011). Economic evaluation of policy options for prevention and control of cervical cancer in Thailand. Pharmacoeconomics, 29, 781-806.
23. Razak NA, Mn K, Zubairi YZ, et al (2013). Estimating the five-year survival of cervical cancer patients treated in hospital universiti sains malaysia. Asian Pac J Cancer Prev, 14, 825-8.
24. Sato S, Matsunaga G, Konno R, et al (1998). Mass screening for cancer of the uterine cervix in Miyagi Prefecture, Japan. Effects and problems. Acta Cytol, 42, 299-304.
25. Sharma M, Ortendahl J, van der Ham E, et al (2012). Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand. BJOG, 119, 166-76.
26. Shi JF, Canfell K, Lew JB, et al (2011). Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. BMC Cancer, 11, 239.
27. Shin HR, Jung KW, Won YJ, et al (2007). National cancer incidence for the year 2002 in Korea. Cancer Res Treat, 39, 139-49.
28. Statistics Korea. (2012). Consumer Price Index in November 2012: Price Statistics Division, Economic Statistics Bureau.
29. Woo PP, Kim JJ, Leung GM (2007). What is the most cost-effective population-based cancer screening program for Chinese women? J Clin Oncol, 25, 617-24.
30. Yamamoto N, Mori R, Jacklin P, et al (2012). Introducing HPV vaccine and scaling up screening procedures to prevent deaths from cervical cancer in Japan: a cost-effectiveness analysis. BJOG, 119, 177-86.
31. Zhao FH, Chen JF, Gao XH, et al (2012). Effectiveness and health economic analysis of strategies on cervical cancer screening and early diagnosis and treatment. Zhonghua Zhong Liu Za Zhi, 34, 632-6.